Medical News

RSS

CCS presents new 2010 Atrial Fibrillation Guidelines

The Canadian Cardiovascular Society (CCS) presented its new 2010 Atrial Fibrillation Guidelines, the first update in six years, at the Canadian Cardiovascular Congress (CCC) in Montreal.

28 Oct 2010

Medical costs per workers' compensation claim in Texas stabilized in 2007: Study

After four years of decreases, medical costs per workers' compensation claim in Texas stabilized in 2007, reflecting the impact of reforms enacted in 2001 and much of those passed in 2005, according to a study by the Workers Compensation Research Institute (WCRI).

28 Oct 2010

Study examines heavy alcohol consumption

Problem drinkers in the general population may reduce the amount of alcohol they consume over a period of years but not to the level of the average adult, according to a new study in the November issue of the Journal of Studies on Alcohol and Drugs.

28 Oct 2010

NICE issues PTNS guidance for overactive bladder

Uroplasty, Inc. announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued a guidance document titled "Percutaneous Posterior Tibial Nerve Stimulation for Overactive Bladder Syndrome," reinforcing the safety and effectiveness of PTNS for overactive bladder.

28 Oct 2010

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

The 4th International Symposium and Workshop on Virtual Interactive Musculoskeletal System, organized by National Cheng Kung University, Taiwanese Society of Biomechanics and Taiwanese Society of Biomechanics in Sports, is held on October 28th and 29th in International Conference Hall, Kuang-Fu Campus, National Cheng Kung University (NCKU), Tainan, Taiwan,

28 Oct 2010

New nationwide initiative to conduct research on human immune system

A new nationwide research initiative has been launched to define changes in the human immune system's response to infection and vaccination using human rather than animal models, which could lead to better vaccines and other treatments. Baylor Research Institute (BRI), along with five other U.S.-based Human Immune Phenotyping Centers, will receive a total of $100 million over five years to conduct the research.

28 Oct 2010

New version of Addiction Severity Index performs well in psychometric terms

The new version of the Addiction Severity Index (ASI) gives health professionals the opportunity to design an integral and personalised plan of assistance for patients suffering disorders due to substance abuse.

28 Oct 2010

Joined-up approach to evaluate childhood obesity programmes

A united front is needed to tackle childhood obesity effectively, according to researchers at the University of Hertfordshire's Weight and Obesity Research Group.

28 Oct 2010

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

Pharmasset, Inc. reported positive preliminary results today from its phase I monotherapy trial of PSI-352938 for the treatment of chronic hepatitis C (HCV). PSI-938 is a guanosine nucleotide analog polymerase inhibitor in development for the treatment of chronic HCV infection.

28 Oct 2010

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

BioCryst Pharmaceuticals, Inc. announced financial results for the third quarter and nine months ended September 30, 2010.

28 Oct 2010

PSS World Medical second quarter net sales decrease 11.7% to $496.2 million

PSS World Medical, Inc. announced today its results for the fiscal 2011 second quarter ended October 1, 2010.

28 Oct 2010

Invacare completes new senior secured credit agreement

Invacare Corporation announced today the completion of a new Credit Agreement establishing a $400 million senior secured revolving credit facility maturing in October 2015.

28 Oct 2010

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

QLT Inc. today announced expansion of the Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber Congenital Amaurosis (LCA) to include patients with Retinitis Pigmentosa (RP), a set of hereditary retinal diseases demonstrating clinical features similar to LCA.

28 Oct 2010

Transcend 2010 third quarter revenue increases 24% to $22,916,000

TRANSCEND SERVICES, INC. a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the third quarter ended September 30, 2010.

28 Oct 2010

United Therapeutics third quarter total revenues increase to $171.0 million

United Therapeutics Corporation today announced its results of operations for the quarter ended September 30, 2010.

28 Oct 2010

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.

28 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

NMA/NBNA releases new consensus report on RSV

Today, the National Medical Association (NMA) and the National Black Nurses Association (NBNA) released a consensus report on RSV. Concerned that recent clinical guidelines published by the American Academy of Pediatrics Committee of Infectious Disease (AAP/COID) may leave some infants unprotected from RSV, the NMA/NBNA RSV Consensus Panel recommended that additional research be conducted to ensure that physicians provide the maximum protection to infants and children at risk of RSV.

28 Oct 2010

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.

28 Oct 2010

Future of health reform legislation and voting for Congressional elections

A comprehensive review of national opinion polls, including newly released data, shows that those who say they intend to vote for a Democratic congressional candidate in 2010 and those who say they intend to vote for a Republican in their district hold starkly different views of what they want the future of health reform legislation to be, mirroring the divide between Democratic and Republican leaders in Congress on this issue.

28 Oct 2010